Last April, I published a short post about the hot Crispr Start-ups. At the time only Editas and Intellia had filed to go public. I could build Crispr Therapeutics cap. table thanks to Swiss registers data. Now Crispr Therapeutics Ag has also filed on Nasdaq (see its S-1). I was not so far from the truth as you may check the new and old cap. tables. Interesting data points…

– Crispr Therapeutics from Nasdaq filing

– Crispr Therapeutics from Swiss register data